Lyell Immunopharma, Inc. (LYEL) free cash flow

Free cash flow · fiscal 2025
-$150.80M

Lyell Immunopharma, Inc. (LYEL) generated free cash flow of -$150.80M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$162.86M. Figures as of 18 Nov 2026, 13:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$150.80M
Highest on record
$23.43Mfiscal 2019
Lowest on record
-$212.36Mfiscal 2020
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Lyell Immunopharma, Inc. free cash flow, in more detail

Across the 7 fiscal years on record (2019–2025), the highest was $23.43M in fiscal 2019 and the lowest -$212.36M in fiscal 2020.

History · 7 fiscal years

Free cash flow by fiscal year

Lyell Immunopharma, Inc. free cash flow, year by year

Lyell Immunopharma, Inc. (LYEL) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$150.80M—
2024-$162.86M—
2023-$166.38M—
2022-$193.83M—
2021-$191.75M—
2020-$212.36M 1,006.5% down
2019$23.43M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on LYEL

Lyell Immunopharma, Inc., figure by figure

Lyell Immunopharma, Inc. (LYEL) overview: price, valuation and scorecard

Lyell Immunopharma, Inc. free cash flow: questions and answers

What is Lyell Immunopharma, Inc.'s free cash flow?

Lyell Immunopharma, Inc. (LYEL) generated free cash flow of -$150.80M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$162.86M.

What are the highest and lowest free cash flow figures on record for Lyell Immunopharma, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $23.43M in fiscal 2019 and the lowest -$212.36M in fiscal 2020.

How is Lyell Immunopharma, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Lyell Immunopharma, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Lyell Immunopharma, Inc. (LYEL) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/LYEL/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.